Follow
Dave L. Dixon
Title
Cited by
Cited by
Year
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna, K Martinod, DL Dixon, ...
Nature Reviews Immunology 21 (5), 319-329, 2021
7422021
The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome
LS Sperling, JI Mechanick, IJ Neeland, CJ Herrick, JP Després, ...
Journal of the American College of Cardiology 66 (9), 1050-1067, 2015
3232015
Collaborative drug therapy management and comprehensive medication management―2015
American College of Clinical Pharmacy, SE McBane, AL Dopp, A Abe, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (4 …, 2015
1962015
Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ...
Circulation: Heart Failure 10 (11), e004373, 2017
1852017
Effects of sodium‐glucose cotransporter 2 inhibitors on 24‐hour ambulatory blood pressure: a systematic review and meta‐analysis
WL Baker, LF Buckley, MS Kelly, JD Bucheit, ED Parod, R Brown, ...
Journal of the American Heart Association 6 (5), e005686, 2017
1842017
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ...
Journal of the American Heart Association 9 (5), e014941, 2020
1722020
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of …
Writing Committee Members, SS Virani, LK Newby, SV Arnold, V Bittner, ...
Journal of the American College of Cardiology 82 (9), 833-955, 2023
1652023
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ...
Circulation: Heart Failure 11 (8), e005036, 2018
1462018
Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study
BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, CR Trankle, ...
Journal of cardiovascular pharmacology 67 (6), 544-551, 2016
1212016
Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP
LF Buckley, DL Dixon, GF Wohlford IV, DS Wijesinghe, WL Baker, ...
Diabetes Care 40 (12), 1733-1738, 2017
1192017
Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week
BS Wiggins, DL Dixon, RR Neyens, RL Page, TJ Gluckman
Journal of the American College of Cardiology 75 (11), 1341-1350, 2020
1152020
Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)
BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ...
Clinical cardiology 40 (9), 626-632, 2017
1142017
2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set …
MM Kittleson, GS Panjrath, K Amancherla, LL Davis, A Deswal, DL Dixon, ...
Journal of the American College of Cardiology 81 (18), 1835-1878, 2023
1032023
Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist
JD Bucheit, LG Pamulapati, N Carter, K Malloy, DL Dixon, EM Sisson
Diabetes technology & therapeutics 22 (1), 10-18, 2020
1002020
Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ...
Basic to Translational Science 2 (5), 513-525, 2017
982017
Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension
N Fatani, DL Dixon, BW Van Tassell, J Fanikos, LF Buckley
Journal of the American College of Cardiology 77 (10), 1290-1299, 2021
772021
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
MK Cheeley, JJ Saseen, A Agarwala, S Ravilla, N Ciffone, TA Jacobson, ...
Journal of Clinical Lipidology 16 (4), 361-375, 2022
742022
Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19)
DL Dixon, BW Van Tassell, A Vecchié, A Bonaventura, AH Talasaz, ...
Journal of cardiovascular pharmacology 75 (5), 359-367, 2020
682020
Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review
SL Littauer, DL Dixon, VK Mishra, EM Sisson, TM Salgado
Pharmacy Practice (Granada) 15 (4), 2017
662017
Additive manufacturing of pharmaceuticals for precision medicine applications: A review of the promises and perils in implementation
M Trivedi, J Jee, S Silva, C Blomgren, VM Pontinha, DL Dixon, ...
Additive Manufacturing 23, 319-328, 2018
642018
The system can't perform the operation now. Try again later.
Articles 1–20